Literature DB >> 15843172

Trehalose and 6-aminohexanoic acid stabilize and renature glucose-6-phosphate dehydrogenase inactivated by glycation and by guanidinium hydrochloride.

Elena Ganea1, John J Harding.   

Abstract

A number of naturally occurring small organic molecules, primarily involved in maintaining osmotic pressure in the cell, display chaperone-like activity, stabilizing the native conformation of proteins and protecting them from various kinds of stress. Most of them are sugars, polyols, amino acids or methylamines. In addition to their intrinsic protein-stabilizing activity, these small organic stress molecules regulate the activity of some molecular chaperones, and may stabilize the folded state of proteins involved in unfolding or in misfolding diseases, such as Alzheimer's and Parkinson's diseases, or alpha1-antitrypsin deficiency and cystic fibrosis, respectively. Similar to molecular chaperones, most of these compounds have no substrate specificity, but some specifically stabilize certain proteins, e.g., 6-aminohexanoic acid (AHA) stabilizes apolipoprotein A. In the present work, the capacity of 6-aminohexanoic acid to stabilize non-specifically other proteins is demonstrated. Both trehalose and AHA significantly protect glucose-6-phosphate dehydrogenase (G6PD) against glycation-induced inactivation, and renatured enzyme already inactivated by glycation and by guanidinium hydrochloride (GuHCl). To the best of our knowledge, there are no data on the effect of these compounds on protein glycation. The correlation between the recovery of enzyme activity and structural changes indicated by fluorescence spectroscopy and Western blotting contribute to better understanding of the protein stabilization mechanism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15843172     DOI: 10.1515/BC.2005.032

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  5 in total

Review 1.  Trehalose as a promising therapeutic candidate for the treatment of Parkinson's disease.

Authors:  Masoomeh Khalifeh; George E Barreto; Amirhossein Sahebkar
Journal:  Br J Pharmacol       Date:  2019-03-27       Impact factor: 8.739

2.  Regulation of plasma fructose and mortality in mice by the aldose reductase inhibitor lidorestat.

Authors:  Hye-Lim Noh; Yunying Hu; Tae-Sik Park; Thomas DiCioccio; Andrew J Nichols; Kazue Okajima; Shunichi Homma; Ira J Goldberg
Journal:  J Pharmacol Exp Ther       Date:  2008-10-30       Impact factor: 4.030

3.  Mass spectrometry characterization of the glycation sites of bovine insulin by tandem mass spectrometry.

Authors:  Sofia Guedes; Rui Vitorino; M Rosário M Domingues; Francisco Amado; Pedro Domingues
Journal:  J Am Soc Mass Spectrom       Date:  2009-03-13       Impact factor: 3.109

4.  An optimised system for refolding of human glucose 6-phosphate dehydrogenase.

Authors:  Xiao-Tao Wang; Paul C Engel
Journal:  BMC Biotechnol       Date:  2009-03-11       Impact factor: 2.563

Review 5.  Potential Fast COVID-19 Containment With Trehalose.

Authors:  Daisy Martinon; Vanessa F Borges; Angela C Gomez; Kenichi Shimada
Journal:  Front Immunol       Date:  2020-07-07       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.